SCHEMBL3017199

SCHEMBL3017199

CC(=O)c1c[nH]c(C(=O)O)c1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PBRM1 Q86U86 1/20 0.39
CSNK2A2 P19784 3/20 0.38
CSNK2B P67870 3/20 0.38
CSNK2A1 P68400 3/20 0.38
F7 P08709 1/20 0.37
F3 P13726 1/20 0.37
DYRK1A Q13627 1/20 0.36
BRPF1 P55201 1/20 0.36
NOTUM Q6P988 3/20 0.33
KDM4E B2RXH2 2/20 0.33
HSD17B10 Q99714 1/20 0.33
PRKAB2 O43741 3/20 0.33
PRKAG1 P54619 3/20 0.33
PRKAA2 P54646 3/20 0.33
PRKAA1 Q13131 3/20 0.33
PRKAG3 Q9UGI9 3/20 0.33
PRKAG2 Q9UGJ0 3/20 0.33
PRKAB1 Q9Y478 3/20 0.33
KDM3B Q7LBC6 1/20 0.32
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3028817 0.79 NR4A2 (0.43) PBRM1BRPF1
SCHEMBL1396183 0.75 NOTUM (0.47) CSNK2A2CSNK2BCSNK2A1DYRK1ANOTUM
SCHEMBL3553024 0.74 CSNK2A2 (0.38) CSNK2A2CSNK2BCSNK2A1F7F3
SCHEMBL21060959 0.72 GABRA1 (0.41) HSD17B10TSHR
SCHEMBL3030002 0.72 NR4A2 (0.43) CSNK2A2CSNK2BCSNK2A1F7F3
SCHEMBL13983016 0.68 KDM4E (0.49) KDM4EHSD17B10TSHR
SCHEMBL6023948 0.68 NOTUM (0.46) CSNK2A2CSNK2BCSNK2A1F7F3
SCHEMBL3023164 0.68 ERN1 (0.33) CSNK2A2CSNK2BCSNK2A1F7F3
SCHEMBL24890364 0.67 NOTUM (0.38) BRPF1NOTUMKDM4EHSD17B10
SCHEMBL5674660 0.66 KDM4E (0.41) CSNK2A2CSNK2BCSNK2A1F7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304419-B2 Chemical compounds GLAXOSMITHKLINE LLC (US) 2012-11-06 US disclosed
US-20100216746-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2010-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216746-A1 CHEMICAL COMPOUNDS SAMHD1, POLRMT, NUDT1 PBRM1 2272/4885CSNK2A2 3843/4885CSNK2B 4068/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.